Bell Investment Advisors’s Kura Oncology KURA Stock Holding History

Bell Investment Advisors’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-20	Closed	–	–	1871
2021 Q3	$0	Buy	+20	New	+$377	﹤0.01%	1780

Other funds holding KURA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Bell Investment Advisors's KURA Position: Q4 2021 in Review

Bell Investment Advisors sold out of Kura Oncology (KURA) in Q4 2021, closing a stake of 20 shares.

Bell Investment Advisors first reported a position in KURA in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 151 funds tracked by Wall St. Rank hold KURA as of Q4 2021.

Bell Investment Advisors reported no remaining Kura Oncology position as of Q4 2021 after selling out during the quarter.
Bell Investment Advisors sold 20 Kura Oncology shares in Q4 2021.
Bell Investment Advisors first reported a position in Kura Oncology in Q3 2021 and held it in 1 quarter.
Bell Investment Advisors's Kura Oncology position peaked at $0 in Q3 2021.
151 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2021.

Based on Bell Investment Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.